Turning Point Therapeutics
San Diego
About Turning Point Therapeutics
Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $1.2B
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2020)
- Ticker: nasdaq:TPTX
- Website: tptherapeutics.com
- Phone: (858)926-5251
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Precision Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/turning-point-therapeutics-182002 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.